Omer Ziv

Omer Ziv

Auto-generated profile, based on publicly available information

Omer Ziv

Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2009 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
SSSigal Shachar
Sigal Shachar
OZOmer Ziv
Omer Ziv
SASharon Avkin
Sharon Avkin
SASheera Adar
Sheera Adar
JWJohn Wittschieben
John Wittschieben
ZLZvi Livneh
Zvi Livneh
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 December 2020 in Molecular Cell
Verified
Journal Article
Open access
OZOmer Ziv
Omer Ziv
JPJonathan Price
Jonathan Price
LSLyudmila Shalamova
Lyudmila Shalamova
TKTsveta Kamenova
Tsveta Kamenova
IGIan Goodfellow
Ian Goodfellow
EMEric A. Miska
Eric A. Miska
The Coronaviridae is a family of positive-strand RNA viruses that includes SARS-CoV-2, the etiologic agent of the COVID-19 pandemic. Bearing the largest single-stranded RNA genomes in nature, coronaviruses are critically dependent on long-distance RNA-RNA interactions to regulate the viral transcription and replication pathways. Here we experimentally mapped the in vivo RNA-RNA interactome of the full-length SARS-CoV-2 genome and subgenomic mRNAs. We uncovered a network of RNA-RNA interactions spanning tens of thousands of nucleotides. These interactions reveal that the viral genome and subgenomes adopt alternative topologies inside cells and engage in different interactions with host RNAs. Notably, we discovered a long-range RNA-RNA interaction, the FSE-arch, that encircles the programmed ribosomal frameshifting element. The FSE-arch is conserved in the related MERS-CoV and is under purifying selection. Our findings illuminate RNA structure-based mechanisms governing replication, discontinuous transcription, and translation of coronaviruses and will aid future efforts to develop antiviral strategies.

10 September 2018 in Nature Methods
Verified
Journal Article
Closed access
PDF file
OZOmer Ziv
Omer Ziv
Marta GabryelskaMarta Gabryelska
Marta Gabryelska
ALAaron T. L. Lun
Aaron T. L. Lun
LGLuca F. R. Gebert
Luca F. R. Gebert
JSJessica Sheu-Gruttadauria
Jessica Sheu-Gruttadauria
EMEric A. Miska
Eric A. Miska

15 February 2010 in Cell Cycle
Verified
Journal Article
Open access
ZLZvi Livneh
Zvi Livneh
OZOmer Z
Omer Z
SSSigal Shachar
Sigal Shachar
The encounter of replication forks with DNA lesions may lead to fork arrest and/or the formation of single-stranded gaps. A major strategy to cope with these replication irregularities is translesi...

14 July 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
OZOmer Ziv
Omer Ziv
NGNicholas Geacintov
Nicholas Geacintov
SNSatoshi Nakajima
Satoshi Nakajima
AYAkira Yasui
Akira Yasui
ZLZvi Livneh
Zvi Livneh
Human cells tolerate UV-induced cyclobutane pyrimidine dimers (CPD) by translesion DNA synthesis (TLS), carried out by DNA polymerase η, the POLH gene product. A deficiency in DNA polymerase η due to germ-line mutations in POLH causes the hereditary disease xeroderma pigmentosum variant ( XPV ), which is characterized by sunlight sensitivity and extreme predisposition to sunlight-induced skin cancer. XPV cells are UV hypermutable due to the activity of mutagenic TLS across CPD, which explains the cancer predisposition of the patients. However, the identity of the backup polymerase that carries out this mutagenic TLS was unclear. Here, we show that DNA polymerase ζ cooperates with DNA polymerases κ and ι to carry out error-prone TLS across a TT CPD. Moreover, DNA polymerases ζ and κ, but not ι, protect XPV cells against UV cytotoxicity, independently of nucleotide excision repair. This presents an extreme example of benefit-risk balance in the activity of TLS polymerases, which provide protection against UV cytotoxicity at the cost of increased mutagenic load.

25 November 2014 in Nature Communications
Verified
Journal Article
Open access
OZOmer Ziv
Omer Ziv
AZAmit Zeisel
Amit Zeisel
NMNataly Mirlas-Neisberg
Nataly Mirlas-Neisberg
USUmakanta Swain
Umakanta Swain
RNReinat Nevo
Reinat Nevo
ZLZvi Livneh
Zvi Livneh
Cells cope with replication-blocking lesions via translesion DNA synthesis (TLS). TLS is carried out by low-fidelity DNA polymerases that replicate across lesions, thereby preventing genome instability at the cost of increased point mutations. Here we perform a two-stage siRNA-based functional screen for mammalian TLS genes and identify 17 validated TLS genes. One of the genes, NPM1, is frequently mutated in acute myeloid leukaemia (AML). We show that NPM1 (nucleophosmin) regulates TLS via interaction with the catalytic core of DNA polymerase-η (polη), and that NPM1 deficiency causes a TLS defect due to proteasomal degradation of polη. Moreover, the prevalent NPM1c+ mutation that causes NPM1 mislocalization in ~30% of AML patients results in excessive degradation of polη. These results establish the role of NPM1 as a key TLS regulator, and suggest a mechanism for the better prognosis of AML patients carrying mutations in NPM1.